Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

Taken from another site with permission of poster... RAConnell.

Meeting Feedback.

Yesterday's meeting with about 20 visitors was better attended than the previous SupraQ meeting in London just under 2 years ago. Attendees seemed to comprise private investors, medics, journalists (Investing for Growth (IFG), a subscription service that rec'd DEMG this summer) and analysts.

The meeting covered 3 areas:
- Updated CardioQ monitor - now entitled CardioQ-ODM.
- R&D
- Manufacture

CardioQ-ODM
The new monitor has more modern, compact component concstruction, additional outputs, is 1Kg lighter, has better screen and comes with a more flexible probe. The (non-invasive) SupraQ has an improved probe that simplifies its use and overcomes previous sensing difficulties caused by patient physiology. DEMG Paul Mitchell (Co. Secy) would not be drawn on specific orders related to improved production capacity but implications are self-evident.

R&D
Main aspects were quicker, cheaper probe design and manufacture.

Manufacture
Focus is on cost cutting through cheaper, streamlined manufacture and testing leading to better productivity. In 2007 125 CardioQ monitors were produced whilst in 2008 50 CardioQ and 350 CardioQ-ODM monitors will be produced. Probe production (via productivity gains) is being increased from 800 pcm to 1400 pcm with increased working resulting in 400,000 probes pa.

Current US market size does not warrant US production and the UK location's increased manufacturing capacity suffices.

Ewen Phillips (CFO)
After these aspects Ewen Phillips (CFO) recapped on technical and cost benefits of ODM, differentiating from other (traditional) alternatives. He indicated that actual usage lags clinical demand while stressing that in USA adoption is later than in UK but once adopted USA use should accelerate beyond that of UK. The UK's adoption of new medical technology (UK developed!) is historically slow.

He was non-committal on capital raising but in discussion with a major private investor (>3% holding) and IFG journalist (German funding obtained this year) it can be assumed that no capital raising is currently planned. Indeed, EP emphasised the focus was on austerity that I take to be reflected by improved productivity, better, cheaper designs and cost-cutting measures.

Summary
DEMG is adequately funded, has improved productivity, lower production costs and increased manufacturing capacity (in UK) of technically improved hardware with focus on cost-cutting and not on capital raising.

So adequate reasons to be patient (no pun intended).

Yet another contract. This one to upgrade the original CardioQ up to the recently released CardioQ-ODM.
Hope this is the start of a steady SP climb and not the usual effect of up on the news and steadily downward in the next few days.
Well done Deltex.

Yes, nice small contract 100 units a month atm with opportunity for this to increase, we need a snowball effect now to push the number of units up. Added to my holding last week, but that's it now, so sit back and wait and wait and wait, but eventually I am convinced this will reward us greekman, maybe with the constraints on health budgets atm DEMG will be forced on the health authorities.
2517

Fully agree. If ever there was a no brainer, this is it. Spend a to save several. Problem is that those that hold the purse strings (government) and those who control the money made available (trusts) don't appear to have a single brain cell between them.
The mind boggles.

Looking interesting, but we have said same before.
But on a rise of +13% on fairly low volume are we about to see that late reported huge buy.
Mind you I predicted that within 3 days of the open day and got it wrong, so my predicting record ain't great, is it !

OK I give up attempting to read this share. Down today over 12%.

In the present market I find I have about as much chance of reading where the sp is heading as my wife does reading a map.

Shame to give up yesterday's gains albeit on low volume, but better times lay ahead for DEMG I'm sure. As for reading the sp of any company, I hold VGM, today the buy/sell ratio (taken at face value) was 80:1 and the sp dropped, so don't feel too bad about reading sp's wrongly, although it would help if your wife was a better map reader ha!ha! Mine is a mind reader, oops got to go she just asked who was I writing to about her ha! ha!
2517

Thanks George,

Not worried about not being able to read sp's at the moment, just find it annoying.

Agree re better times for Deltex.

According to todays Daily Telegraph, the NHS recorded a surplus last year of 2.1bn. The Department of Health stated that it was up to individual trusts to decide how the surplus would be used for the benefit of patients.
Just think 2,100,000,000.
Lets look at a couple of options.

Option A....Spend some of this on putting as many CardioQ,s as required in every hospital, leaving a huge amount to spend on other life saving technologies.

Option B....Spend all of it on plush new offices for the top heavy administration.
New carpets, expensive wallpaper, furniture perhaps.
And of course not forgetting all those extra overseas (I understand the Bahamas are nice this time of year) conferences that are essential for the understanding of these job worthies.

Call me a cynic (yes I know someone will) but option B looks a certain bet.

Absolutely greekman, you don't expect this surplus to be frittered away on patient care do you, it's all about the feelgood factor, the hierarchy, not the patients. As for you being cynical, mmmm, you're probably no more cynical than me, anyway these bb's already have their own cynic whose posts are eagerly read by many of us. (I suspect there are a good many cynics out there in reality,and with good cause)
2517

Surely this must be a catalyst as far as the CardioQ is for the UK market.

Found on another site.

The NHS are awaiting a report.

http://www.ncchta.org/project/1633.asp

Looks like Deltex CardioQ is/will lead the way as its easier an cheaper to use as well as (from all the data) the best performing.
Whilst I appreciate the powers that be have to have their own assessments, you would have thought all they would have needed to do was to collate and review all the ODM data that is already out there. Also you would have though all this should have been completed months, if not years ago.
Procrastination rules, yet again.
But we are still heading in the right direction, are we not.
With such assessments, the conclusion is never a sure bet.

Re the above post.
The NHS are expecting a report.

Report updated, (but don't get excited) as all that has been updated is the date 17-12-08.

As the problem is re these reports, you can not get the earlier report once the site has been updated.
As I am keeping copies to compare, I will post any changes, in said reports.

Greek

Nice steady tick up over last 5 trading day. Up 17% plus today on low volume. In the current markets I would have expected some pull back, by now on no news.
I am expecting a pre close trading statement soon as they released one last year. It was on the 23rd Jan. Can't see any reason not to release one this year, similar time.
Also, as the assessment on the CardioQ system by the NHS CENTRE FOR EVIDENCE-BASED PURCHASING (CEP) is due an update on 13th of this month timing could be perfect for a sp surge, obviously counting on a positive update that is but with 2 delays already, don't hold your breath. It does make you wonder why the NHS have to sit on this for so long, when all the evidence to prove evidence based purchase (positive) is literally starring them in the face. Just how much more evidence do these muppets need.

Yes has improved nicely and despite saying I had enough I did a small top up on 31/12 that really is it now. I think this has the potential to go quite well in terms of the sp, like you say the evidence is there, it just needs to be recognised by the purse holders, and slowly but surely this is happening.
2517

As I understand it although the powers that be (NHS Trusts) don't have to follow recommendations made by THE NHS CENTRE FOR EVIDENCE-BASED PURCHASING (CEP) they would find it very difficult to not follow the said recommendations, if it is shown that the product shows best value for money.
An interesting explanation re what they (CEP) do.
http://www.pasa.nhs.uk/PASAWeb/NHSprocurement/CEP

Don't hold your breath.

The NHS (CEP) projects are listed in order of intended publication date, soonest first. There are 14 that have an intended publication date prior to the Deltex connected one. The project top of the list still has an intended publication date of early 2008. Yes that's not a typo error, 2008 is correct. So no doubt we will see many updates, where the only difference is yet another update due date. No wonder nothing ever gets done.
Pathetic or what.
Lets just hope that the list is juggled about a bit, if/when obstacles are overcome.
When the project is finally published, I will receive a full project report, so will post here.
If I live that long.

NHS (CEP) update or not.
The only update is yet again another report estimated date, now being 20/01/09.

Due to the almost static none action by the above (still 14 projects with priority dates earlier than the CadioQ assessment) I have sent the following E-Mail to the NIHR.

I am conducting research on the workings of the NIHR Health Technology Assessment programme.

You state that, 'Projects are listed in order of intended publication date, soonest first. Followed by completed projects that do not require publication'.

Often these so called publication dates have passed. Please see example below which is the first project on your current list, which is still showing Estimated Publication date of Early 2008. As it is now 2009 how can this estimated date still be relevant. This gives the impression that proposed dates are just churned over, with no real information of progress. If estimated publication dates are up to 12 months out, what's the point of publishing said estimated dates.

Example..This is the first on the list.
Docetaxel for the adjuvant treatment of early breast cancer. HTA Ref: 05/53/01.
Research Type: NICE Evidence Review Group Report (ERG).
(ERG report received)
Estimated publication date in Supplement to the HTA journal series: Early 2008.
END.

I will no longer post info re this unless there IS an update of any relevance.
I will of course post any reply from my e-mail (don't hold your breath as I am not expecting one).
The CardioQ project was first looked at by the above in March 2007. This just goes to show the huge huddles that Deltex have to overcome.
Slow, slow stop should be the motto of the NIHR.

Sadly this is an all too common occurrence these days, in as much as people in prominent positions gladly keep taking the money and do diddley squat for it, some MP's, bankers, the social services and the NHS, to name just a few. I look forward to reading any reply you may get greekman, course the danger is if they do respond to your e-mail it will put the update back another 12 months.
I hasten to add there are a good many very hard working people in the occupations above, it just seems to be the decision makers who are not up to the task.
2517

Fully agree. Plenty of hard working indians, with even more none productive chiefs.
But as long as failure or/and none productivity is rewarded, nothing will change.

NIHR HTA programme up date.
It appears that although the next stated update from the last (13/01/09) was to be today, but for some reason an update was published on 16/01/09.
The good news is the project at the top of the list now has a estimated publish date of Jan 2009, whereas a few weeks ago such dates were Jan 2008, so somewhat out of date (I would like to think my e-mail giving a diplomatic kick up the ass did it, but I doubt it very much).
The point is since the 13th, seven projects have been published leaving Deltex Cardio now 8th on the projected publishing timescale (from 14th a week ago).
Might not mean much but at least their (Deltex) project is moving nearer the top in priority.
Will post further update after market close tonight.
Hope I'm not going to deep re this (boring) but I feel the result of this project research paper will be a main catalyst in the take up of the Cardio system in the UK.

Note. I am now signed up with the NIHR HTA programme so will be informed of any updates as and when they occur. I will also receive notification as/when the Deltex project is published, so will post immediately, although there will probably be a RNS at the same time.